No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Age Factors
-
Aged
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Clinical Trials as Topic
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Dose-Response Relationship, Drug
-
Doxorubicin / administration & dosage
-
Female
-
Germany
-
Humans
-
Immunotherapy
-
International Cooperation
-
Lymphoma, Non-Hodgkin / classification
-
Lymphoma, Non-Hodgkin / drug therapy
-
Lymphoma, Non-Hodgkin / mortality
-
Lymphoma, Non-Hodgkin / pathology
-
Lymphoma, Non-Hodgkin / therapy*
-
Male
-
Middle Aged
-
Prednisone / administration & dosage
-
Prognosis
-
Radiotherapy, Adjuvant
-
Remission Induction
-
Risk Factors
-
Rituximab
-
Severity of Illness Index
-
Treatment Outcome
-
Vincristine / administration & dosage
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone